Drug
Nplate
Nplate is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
1
25%
Ph phase_2
1
25%
Ph phase_3
2
50%
Phase Distribution
1
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
2(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(1)
Other(1)
Detailed Status
unknown1
Active, not recruiting1
Completed1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 11 (25.0%)
Phase 21 (25.0%)
Phase 32 (50.0%)
Trials by Status
unknown125%
active_not_recruiting125%
completed125%
not_yet_recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
not_yet_recruitingphase_2
Preoperative Use of Romiplostim in Thrombocytopenic Patients Undergoing Cardiac Surgery.
NCT07278661
active_not_recruitingphase_3
Study of Efficacy, Safety and Immunogenicity of GP40141 (GEROPHARM, Russia) in Patients With Immune Thrombocytopenia
NCT06497036
completedphase_3
Comparative Study of Clinical Efficacy and Safety of GNR-069 and Nplate in Patients With ITP
NCT05220878
unknownphase_1
Double-blind, Randomized Comparative Cross-sectional Study of Pharmacodynamics and Pharmacokinetics of Drugs GP40141
NCT05652595
Clinical Trials (4)
Showing 4 of 4 trials
NCT07278661Phase 2
Preoperative Use of Romiplostim in Thrombocytopenic Patients Undergoing Cardiac Surgery.
NCT06497036Phase 3
Study of Efficacy, Safety and Immunogenicity of GP40141 (GEROPHARM, Russia) in Patients With Immune Thrombocytopenia
NCT05220878Phase 3
Comparative Study of Clinical Efficacy and Safety of GNR-069 and Nplate in Patients With ITP
NCT05652595Phase 1
Double-blind, Randomized Comparative Cross-sectional Study of Pharmacodynamics and Pharmacokinetics of Drugs GP40141
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4